RSNA Conference Extension Page

Find product info and watch case studies

Watch NeuroQuant case studies for the assessment of Alzheimer’s disease

Age-Related Atrophy Report

Watch OnQ Prostate case study for the assessment and detection of prostate cancer

OnQ Prostate

Watch our RSNA AI Theater Presentation

NeuroQuant, LesionQuant, and OnQ Prostate case studies

VIDEO: Quantitative Imaging for Dementia, Case review with Dr. Bash

This is the first in a series of case reviews using quantitative imaging in the assessment of various diseases. Dr. Bash, neuroradiologist at RadNet, uses NeuroQuant and other tools in her review of 7 patient cases.

OnQ Prostate, case study for the assessment and detection of prostate cancer

Dr. Schwazrtzberg uses OnQ Prostate to assess prostate cancer. He evaluates the case using T2, DWI, and ADC, then reviews an RSI map and color fusion map provided by OnQ Prostate. He demonstrates how RSI increases conspicuity and how, in this case, it informs his designation of the PI-RADS number.

Join Dr. Schwartzberg and Dr. White on Dec. 3rd

We will review and discuss the benefits of OnQ Prostate for the detection of clinically significant prostate cancer using an advanced diffusion MRI technique called Restriction Spectrum Imaging (RSI). Dr. Schwartzberg shares cases from his practice at Imaging Healthcare Specialists in San Diego, California, where the use of OnQ Prostate has resulted in better, more accurate PI-RADS scoring than with conventional DWI/ ADC.

Register

RSNA AI Theater Presentation

Dr. Bash uses NeuroQuant in the assessment of Alzheimer’s disease and reviews the features and benefits of LesionQuant and discusses the lesion detection threshold settings that enable each site to configure the minimum lesion size and the sensitivity within the infratentorial, leukocortical, periventricular, and white matter regions. She reviews lesion counts and volumetrics, as well as several overlay series that inform her diagnoses. Dr. Schwazrtzberg uses OnQ Prostate to assess prostate cancer. He evaluates the case using T2, DWI, and ADC, then reviews an RSI map and color fusion map provided by OnQ Prostate. He demonstrates how RSI increases conspicuity and how, in this case, it informs his designation of the PI-RADS number.

  • You can include your preferred date and time, or just ask your question here and we will respond to your email.

Contact Us

Would you prefer to add a date and time directly to a calendar? Click here to schedule a discovery meeting.